Hold up — major win in the cancer fight! The FDA just gave the green light to Penpulimab-kcqx for treating nasopharyngeal carcinoma (NPC). Yep, it’s official — Akeso Biopharma’s drug is now approved for U.S. patients battling this tough cancer type. And trust us, this approval is a huge deal! First up, Penpulimab can now […]